Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 284

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 284
---
 of assets are capitalized.

The cost and related accumulated depreciation
of assets sold or otherwise retired are removed from the accounts and any gain or loss is included in the unaudited interim condensed
consolidated statements of (loss) income and comprehensive (loss) income.

Long-lived assets are evaluated for impairment
periodically whenever events or changes in circumstances indicate that their related carrying amounts may not be recoverable in accordance
with FASB ASC 360, “Property, Plant and Equipment”. In evaluating long-lived assets for recoverability, the Company
uses its best estimate of future cash flows expected to result from the use of the asset and eventual disposition in accordance with
FASB ASC 360-10-15. To the extent that estimated future undiscounted cash inflows attributable to the asset, less estimated future
undiscounted cash outflows, are less than the carrying amount, an impairment loss is recognized in an amount equal to the difference
between the carrying value of such an asset and its fair value. Assets to be disposed of and for which there is a committed plan of disposal,
whether through sale or abandonment, are reported at the lower of carrying value or fair value less costs to sell. There were no impairments
of these assets as of September 30, 2024 and March 31, 2024.

The Company utilizes ASC 842 to account for
leases for all periods presented.

The Company determines if an arrangement is
a lease at inception. On the Company’s unaudited interim condensed consolidated balance sheets, right-of-use (“ROU”)
assets, current portion of lease liabilities, and non-current portion of lease liabilities are accounted.

<div align='center'>F-32</div>

ROU assets and lease liabilities are recognized
based on the present value of the future minimum lease payments over the lease term at commencement date. As the Company’s leases
do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date
in determining the present value of future payments. The ROU asset also includes any lease payments made and initial direct costs incurred
and excludes lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably
certain that the Company will exercise that option. For leases that have lease terms of 12 months or less and does not include a purchase
option that is reasonably certain to exercise, the Company elected not to apply ASC 842 recognition requirements. Lease expenses for
minimum